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Abstract: 
Background: We aimed at characterizing the aging gingiva analyzing: i) collagen content and turnover in human gingival 
tissues and fibroblasts obtained from healthy young and aging subjects. ii) the effect of cyclosporin A administration in 
human cultured gingival fibroblasts obtained from aging compared to young subjects. 
Methods: Morphological analysis was performed on haematoxylin-eosin and Sirius red stained paraffin-embedded gingi-
val biopsies from young and aging healthy subjects. The expression of the main genes and proteins involved in collagen 
turnover were determined by real time PCR, dot blot and SDS-zymography on cultured young and aging gingival fibro-
blasts, and after cyclosporin A administration.  
Results: Our results suggest that in healthy aged people, gingival connective tissue is characterized by a similar collagen 
content and turnover. Collagen turnover pathways are similarly affected by cyclosporin A treatment in young and aging 
gingival fibroblasts.  
Conclusions: Cyclosporin A administration affects gingival collagen turnover pathways in young and aging fibroblasts at 
the same extent, suggesting that during aging cyclosporin A administration is not related to relevant collagen turnover 
modifications. 
Keywords: Aging, gingiva, collagen turnover, matrix metalloproteinases, SPARC, cyclosporin A, gingival overgrowth. 
INTRODUCTION 
The oral cavity is formed by different specialized tissues 
that synergistically concur at least in three essential physio-
logical functions in humans: phonation, nutrition, and de-
fence of the host against a variety of pathogens, i.e. xenobi-
otics, bacteria, viruses and mycetes. In healthy aging, these 
tasks are modestly affected, but oral health declines, possibly 
due to the age-related ability of the different tissues to main-
tain homeostasis. In fact, the oral cavity frequently manifests 
secondary effects of numerous systemic diseases and treat-
ments during aging. The most relevant signs are a higher 
susceptibility to caries associated with xerostomia, periodon-
tal inflammation and fungal infections. In this scenario, life 
style, medical conditions and therapeutic regimens, often 
concomitant in older persons, represent the major determi-  
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nant. Moreover, poor oral health care, and dental or perio-
dontal chronic infections could mediate weight change 
through alterations in diet and nutritional status, and also 
favour systemic effects [1-3].  
Although a considerable amount of data are available re-
garding the effects of aging on the main tissues of the oral 
cavity, such as teeth, salivary glands, and periodontium [4, 
5], very few studies investigated the age-related changes 
involving the gingiva [6]. 
A variety of age-related periodontal changes occur and, 
although controversial, earlier studies on aging gingiva 
showed that the metabolism of both collagen and non-
collagenous proteins decreases with increasing age [7]. Age-
dependent modifications were also found in the fibroblast 
size [8], and in the mitotic activity of both gingival fibro-
blasts and epithelial cells [9, 10].  
Qualitative and quantitative changes in gingival connec-
tive tissue are prominent features of periodontal diseases. A 
disturbance in connective tissue homeostasis, mainly involv-
ing interstitial collagen as the major structural protein in gin-220    The Open Dentistry Journal, 2009, Volume 3  Gagliano et al. 
gival connective tissue, has been suggested as one of the 
most relevant events occurring in the development of drug-
induced gingival overgrowth (GO), a pathology character-
ized by increased accumulation of interstitial collagen in the 
gingival connective compartment [11-13].  
As previously reported, older people are susceptible to a 
higher incidence of multiple chronic disease and conditions 
compared with younger adults. As a consequence, they con-
sume a greater number of prescription and non-prescription 
medications and, due to the age-associated changes of phar-
macokinetic and pharmacodynamic properties, the elderly 
population is at greatest risk for medication-related problems 
that may very likely affect gingival connective homeostasis 
[14, 15].  
Since the overall age-related gingival connective tissue 
modifications have still not been fully described [16], in the 
present study we combined different analytical approaches 
aimed at characterizing the complex mechanisms that control 
collagen turnover in aging gingival fibroblasts. In particular 
we aimed at: i) analyzing collagen content in young and ag-
ing gingivae, and the complex regulatory mechanisms that 
control collagen turnover in aging gingival fibroblasts using 
morphological and molecular approaches. ii) analyzing the 
effect of cyclosporin A on collagen turnover mechanisms in 
healthy aged gingival fibroblasts, compared to young ones in 
order to understand if older people are able to maintain tissue 
homeostasis or are more susceptible to the development of 
drug-induced gingival overgrowth. 
This information might contribute to a better understand-
ing of some of the modifications which gingiva undergoes 
with aging, providing a baseline to appraise the quantitative 
pathological changes of collagen turnover in disease states, 
and to understand the potential effect of pharmacologic 
treatment on gingival connective tissue. 
MATERIALS AND METHODOLOGY 
Experimental Model 
Gingival biopsies were obtained from 5 young (mean age 
36 ± 9.23, 4 females and 1 male) and 7 aging subjects (mean 
age 70.17 ± 10.63, 4 females and 3 males). All subjects were 
no smokers, had clinically normal gingiva, with no signs of 
overt inflammation, hyperplasia and no history of drug use 
associated with GO, without any systemic health problems. 
Health, drugs, alcohol abuse and smoking histories were 
collected to exclude patients with known clinical situation 
able to affect the gingival status. They gave their informed 
consent to the biopsy, which was obtained from attached 
gingiva under local anaesthesia during minor oral surgical 
procedures. Each gingival biopsy was divided into two 
fragments: one fragment was processed for morphologic 
analysis and one fragment for cell culture evaluations.  
Histochemistry and Image Analysis 
Immediately after surgery, each gingival biopsy fragment 
was fixed in 10% formalin in 0.1M phosphate buffer saline 
(PBS), pH 7.4, for 5 hours at room temperature, routinely 
dehydrated, paraffin embedded, and serially sectioned 
(thickness 5 μm). Sections were stained with freshly made 
haematoxylin-eosin to evaluate the tissue morphology. To 
specifically stain collagen, slides were deparaffinized and 
immersed for 30 minutes in saturated aqueous picric acid 
containing 0.1% Sirius red F3BA (Sigma, Italy). 
All of the Sirius red-stained sections were analyzed by 
light microscopy and the images were captured and digitized 
using an image analysis system with specific software (Bio 
Image Analyzer, ICH, Italy). This software automatically 
selects the collagenous portion on the basis of similarities in 
the colour of adjacent pixels, based on a RGB system. Tissue 
COL content is expressed by a fibrosis index (%), indicating 
the ratio of the mean Sirius red-stained surface to the whole 
area of the section. 
Cell Culture 
Human gingival fibroblasts were obtained from the 
young and aging subjects. Gingival biopsies were washed 
with sterile PBS, plated in T-25 flasks, incubated in DMEM 
supplemented with 10% heat-inactivated fetal bovine serum 
(FBS) and antibiotics (100 U/mL penicillin, 0.1 mg/mL 
streptomycin) at 37°C in a humidified atmosphere containing 
5% CO2. When fibroblasts grew out from the explant, they 
were trypsinized (0.25% trypsin-0.2% EDTA) for secondary 
cultures. Viability was assessed by the Trypan blue exclu-
sion method. Confluent human gingival fibroblasts were 
used between the fourth and fifth passage. 
Molecular evaluations were done on fibroblasts cultured 
for 72 h, using duplicate cultures for each sample. 
Treatment of Gingival Fibroblasts with CsA 
When human gingival fibroblasts grew to confluence in 
T-75 flasks, the culture medium was replaced with serum-
free DMEM containing 2 doses of CsA (252 and 800 ng/ml) 
dissolved in a vehicle (0.008% ethanol, 0.0016% Tween-20). 
The lower dose corresponds to the whole blood trough levels 
of CsA. The higher dose was reported to induce modifica-
tions of proliferation and ECM turnover, and to affect colla-
gen homeostasis in gingival fibroblasts obtained from young 
healthy subjects [12]. The cultures were then incubated at 
37°C for 72 h. To assess CsA effect, cultured fibroblasts of 
each sample incubated in CsA vehicle served as controls 
(VH). At the established intervals of time the cell culture 
supernatants were collected and fibroblasts were washed in 
PBS, trypsinized and harvested by centrifugation (100 xg, 5 
min). 
Real-time RT-PCR 
Total RNA was isolated by a modification of the acid 
guanidinium thiocyanate-phenol-chloroform method (Tri-
Reagent, Sigma, Italy). One μg of total RNA was reverse-
transcribed in 20 μL final volume of reaction mix (Biorad, 
Italy). mRNA levels of collagens type I (COL-I), long lysyl 
hydroxylase 2 (LH2b), matrix metalloproteinase 1 (MMP-1), 
tissue inhibitor of MMP (TIMP-1), Secreted Protein Acidic 
and Rich in Cysteine (SPARC), transforming growth factor-
1 (TGF-1) were assessed. 
The primers sequences, designed with Beacon Designer 
6.0 Software (BioRad, Italy), were the following: GAPDH: 
sense CCCTTCATTGACCTCAACTACATG, antisense TG 
GGATTTCCATTGATGACAAGC; COL-I: sense CGAC 
CTGGTGAGAGAGGAGTTG, anti-sense AATCCATCCA 
GACCATTGTGTCC; MMP-1: sense CGGATACCCCA A 
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TCATGTGC; TGF-1: sense GTGCGGCAGTGGTTG AGC, 
antisense  GGTAGTGAACCCGTTGATGTCC; TIMP-1: 
sense GGCTTCTGGCATCCTGTTGTTG, antisense AAGG 
TGGTCTGGTTGACTTCTGG; LH2b: sense CCG GAAA 
CATTCCAAATGCTCAG, antisense GCCAGAGGT CATT 
GTTATAATGGG; SPARC: sense GCGAGCTG GATGA-
GAACAACAC, antisense GTGGCAAAGAAGT GGCAG-
GAAG. 
GAPDH was used as endogenous control to normalize 
the differences in the amount of total RNA in each sample. 
Amplification reactions were conducted in a 96-well plate in 
a final volume of 20 μL per well containing 10μL of 1x 
SYBR Green Supermix (BioRad, Italy), 2 μL of template, 
300 pmol of each primer, and each sample was analysed in 
triplicate. The cycle threshold (Ct) was determined and gene 
expression levels relative to that of GAPDH were calculated 
by the 2
-Ct method, according to Livak and Schmittgen 
[17]. 
Slot Blot 
Cell culture media from young and aging fibroblasts 
were concentrated 20-fold with Centricon 10 columns (Ami-
con Y10, Millipore, Italy). Protein content was determined 
by a standardized colorimetric assay (DC Protein Assay, Bio 
Rad, Italy); 20 μg of total protein per sample in a final vol-
ume of 200 μL of Tris buffer saline (TBS) were spotted onto 
a nitrocellulose membrane in a Bio-Dot SF apparatus (Bio-
Rad, Italy). Membranes were blocked for 1 h with 5% 
skimmed milk in TBST (TBS containing 0.05% tween-20), 
pH 8, and incubated for 1 h at room temperature in mono-
clonal antibody to COL-I (1:1000 in TBST) (Sigma, Italy) or 
to COL-III (1:2000 in TBST) (Sigma, Italy). After washing, 
membranes were incubated in HRP-conjugated rabbit anti-
mouse serum (1:80,000 in TBST) (Sigma, Italy) for 1 h. 
Immunoreactive bands revealed by the Amplified Opti-4CN 
substrate (Amplified Opti-4CN, Bio Rad, Italy) were 
scanned densitometrically (UVBand, Eppendorf, Italy).  
MMP-1 protein expression in VH and CsA treated fibro-
blasts was assessed by slot blot. The membranes were incu-
bated overnight at 4°C in monoclonal antibody to MMP-1 (1 
μg/ml in TBST, Calbiochem) and, after washing, in HRP-
conjugated rabbit anti-mouse serum (1:80,000 dilution, 
Sigma).  
SDS-zymography 
Concentrated culture media were mixed 3:1 with sample 
buffer (containing 10% SDS). Samples (five μg of total pro-
tein per sample) were run under non-reducing conditions 
without heat denaturation onto 10% polyacrylamide gel 
(SDS-PAGE) co-polymerized with 1 mg/mL of type I gela-
tin. The gels were run at 4°C. After SDS-PAGE, the gels 
were washed twice in 2.5% Triton X-100 for 30 min each 
and incubated overnight in a substrate buffer at 37°C (Tris-
HCl 50 mM, CaCl2 5 mM, NaN3 0.02%, pH 7.5). The matrix 
metalloproteinase (MMP) gelatinolytic activity was detected 
after staining the gels with Coomassie brilliant blue R250, as 
clear bands on a blue background.  
Western Blot 
Concentrated culture media (5 μg of total proteins) were 
diluted in SDS-sample buffer, loaded on 10% SDS-
polyacrylamide gel, separated under reducing and denaturing 
conditions at 80 V according to Laemmli, and transferred at 
90 V to a nitrocellulose membrane in 0.025 M Tris, 192 mM 
glycine, 20% methanol, pH 8.3. After electroblotting, the 
membranes were air dried and blocked for 1 hour. After be-
ing washed in TBST (TBS/Tween-20 0.05%), membranes 
were incubated for 1 h at room temperature in monoclonal 
antibody to SPARC (1:100 in TBST, Novocastra Laborato-
ries) and, after washing, in HRP-conjugated rabbit anti-
mouse serum (1:6000 dilution, Sigma, Italy). Immunoreac-
tive bands were revealed using the Opti-4CN substrate Bio 
Rad. 
Statistical Analysis 
All amplifications were run in triplicate, and all of the 
evaluations were repeated two times. To compare the young 
and aging untreated fibroblasts, data were analyzed by an 
unpaired t-test, and the age was the independent variable. 
The hypothesis was 2-tailed. To assess the effects of aging 
and CsA administration, data were analyzed by 2-way 
ANOVA. p values less than 0.05 were considered signifi-
cant. A post hoc assessment of the power of the t-test [18] 
and the variance test made using the non-central F-
distribution [19] was performed. 
RESULTS 
Our first aim was to characterize collagen content and 
turnover in both gingival tissues and cultured gingival fibro-
blasts obtained from healthy young and aging subjects. 
Morphological and Quantitative Image Analysis 
Under light microscopy haematoxylin-eosin stained sec-
tions of young and aging samples appeared similar (Fig. 1a, 
b). In the epithelium of the two experimental groups we ob-
served a similar number of the living cell layers, excluding 
the presence of acanthosis. The rete peg was similarly pro-
longed in both experimental groups, and regularly elongated. 
The connective tissue included a similar amount of collagen 
fiber bundles running in all directions, with some inflamma-
tory cell infiltration which tended to be more abundant in 
some of the aging gingival fragments.  
Sirius red stained the collagen specifically and computer-
ized analysis of sections of gingiva from young and aging 
subjects indicated that the fibrosis index was, respectively, 
83.5% ± 6.29 and 82.5% ± 4.74 (Fig. 1c, d). 
Gene Expression 
mRNA levels are shown in Fig. (2a). COL-I gene expres-
sion decreased in aging fibroblasts compared to the young 
ones (p<0.05). A tendency to decrease was observed for 
TIMP-1 (p = 0.068), while MMP-1 and TGF-1 mRNA lev-
els were unchanged (p ns). LH2b mRNA levels in aging fi-
broblasts were unaffected. Interestingly, if we consider the 
LH2b/COL-I mRNA ratio, there was a significant increase 
(p< 0.05) of this ratio in aging fibroblasts compared to young 
ones.  
COL Protein Levels 
COL-I and COL-III protein levels were assessed in fi-
broblast supernatants by slot blot. Densitometric scanning of 222    The Open Dentistry Journal, 2009, Volume 3  Gagliano et al. 
immunoreactive bands showed that COL-I and COL-III con-
tent was not affected by aging (data not shown).  
COL Degradation 
MMP-1 and MMP-2 protein levels in young and aging 
fibroblast supernatants is presented in Fig. (2b, 2c). The den-
sitometric analysis of lytic bands identified as MMP-1 re-
vealed similar levels of interstitial collagenase in the super-
natants obtained from young and aging subjects (Fig. 2b, c). 
This result was confirmed by slot blot analysis (data not 
shown). Also MMP-2 protein levels seems unaffected by 
aging (Fig. 2b, c).  
SPARC Expression 
SPARC mRNA levels tended to be lower in aging com-
pared to young fibroblasts (0.46 ± 0.08 and 0.96 ± 0.079, 
respectively, p ns). SPARC protein levels, however, were not 
significantly affected by the aging process (young 195095 ± 
110644, aging 170894 ± 173511, p ns). 
Post hoc power assessment of the statistical test revealed 
that the power was >0.90 for COL-I and SPARC gene ex-
pression, indicating that the analysis had not type II errors. 
The power was comprised between 0.4 and 0.6 for MMP-1 
mRNA, TIMP-1 mRNA and LH2b/COL-I mRNA ratio, and 
was <0.2 for LH2b and TGF-1 mRNA levels, indicating 
that the analyses had a type II errors. 
Effect of CsA on Collagen Turnover in Young and Aging 
Fibroblasts 
Our second aim was to characterize if collagen turnover 
was affected by CsA administration at a different extent in 
cultured gingival fibroblasts obtained from healthy young 
and aging subjects. 
Gene Expression 
COL-I gene expression (Fig. 3a) was not affected by 
CsA administration both in young and in aging fibroblasts (p 
[age] < 0.0005, p [treatment] = ns, p [interaction]= ns). A 
similar pattern was observed for MMP-1 (p [age] = ns, p 
[treatment] = ns, p [interaction]= ns) (Fig. 3b), TIMP-1 (p 
[age] < 0.05, p [treatment] = ns, p [interaction]= ns) (Fig. 
3c), TGF-1 (p [age] = ns, p [treatment] = ns, p [interac-
tion]= ns) (Fig. 3d), LH2b (p [age] = ns, p [treatment] = ns, p 
[interaction]= ns) (Fig. 3e), and SPARC mRNA levels (p 
[age] = ns, p [treatment] = ns, p [interaction]= ns) (Fig. 3f).  
COL Protein Levels 
COL-I protein levels were assessed in fibroblast super-
natants by slot blot. Densitometric scanning of immunoreac-
tive bands showed that COL-I levels tended to be higher in 
CsA-treated young fibroblasts, and were not modified by 
CsA in aging fibroblasts (Fig. 4 a).  
COL Degradation 
MMP-1 protein levels in young and aging fibroblast su-
pernatants is presented in Fig. 4 b. MMP-1 protein levels 
tended to be down-regulated in CsA-treated young fibro-
blasts, compared to VH. In aging fibroblasts we observed a 
wide interindividual variation and a tendency to decrease 
after 800 ng/ml CsA, compared to VH (p [age] = ns, p 
[treatment] = ns, p [interaction]= ns). MMP-2 activity was 
unchanged after CsA administration in both young and aging 
fibroblasts (p [age] = ns, p [treatment] = ns, p [interaction]= 
ns) (data not shown). 
SPARC Expression 
SPARC protein levels were unchanged by CsA admini-














Fig. (1). Microphotographs of young and aging gingiva paraffin-embedded sections stained with hematoxylin-eosin (a, b) or with Sirius red 
(c, d). a and c: young gingiva; b and d: aging gingiva. Original magnification: 10X. Gingival Collagen Turnover During Aging  The Open Dentistry Journal, 2009, Volume 3    223 
= ns, p [treatment] = ns, p [interaction]= ns) (Fig. 4c), as 
observed for SPARC mRNA levels (p [age] = ns, p [treat-
ment] = ns, p [interaction]= ns).  
Post hoc power assessment of the statistical test revealed 
that the power was comprised between 0.88 and 0.99 for 
COL-I mRNA and protein levels, MMP-1 mRNA and pro-
tein levels, and TIMP-1 mRNA levels, suggesting that the 
analysis had not type II errors. For the remnant evaluations, 
the power was comprised between 0.30 and 0.40, indicating 
that the analyses had type II errors. 
DISCUSSION 
Chronic diseases are common among older people and 
increase the necessity for multiple medications. Polipharma-
cotherapy, together with the well established changes of the 
pharmacokinetic processes, render the elderly more suscepti-
ble to the adverse effects of drugs [20].  
Periodontal tissue is susceptible to a range of systemic 
medications able to promote unwanted effects (e.g. GO), and 
the gingiva may be therefore a target of adverse reactions, 
particularly in the elderly.  
Collagen is the main component of gingival connective 
compartment. Its turnover is a vital step in the tissue remod-
elling that accompanies physiological and pathological proc-
esses, and its age-dependent imbalance is a hallmark of the 
aging of various organs, i.e. heart and the kidney [21, 22], 
but very few data are available regarding the gingiva. 
Gingival connective tissue undergoes a rapid rate of col-
lagen turnover [23], therefore all of the mechanisms in-
volved (collagen synthesis, maturation, and degradation) are 
of considerable importance in the net collagen steady-state, 
in which MMPs play a pivotal role [24]. MMPs with colla-
genase and gelatinase activities are secreted in the extracellu-
lar space as zymogens and are activated by proteolytic cleav-
age; their activity is closely regulated and under pathological 
conditions any mismatch could result in excessive ECM ac-
cumulation or degradation.  
Interstitial collagenase or MMP-1 cleaves the native tri-
ple helical region of interstitial COL into characteristic 3/4- 
and 1/4-collagen degradation fragments [25], allowing its 
further digestion by less specific proteinases, leading to 
complete digestion of fibrillary COL. 
The extracellular activity of MMPs is tightly regulated at 
various points, including inhibition by TIMPs, among which 
TIMP-1 and 2 are the most important since they inhibit the 
active form of all MMPs, forming inactive 1:1 stoichiometric 
TIMP-1/MMP-1 complexes [26, 27].  
During COL maturation, post-translational hydroxylation 
of COL lysine residues, accomplished by lysyl hydroxylase 
(LH) is a key mechanism influencing collagen biosynthesis 
and extracellular matrix stability [28]. Two alternately-
spliced forms of LH2 exist, the long (LH2b) and the short 
(LH2a) ones [28]. We investigated LH2b gene expression, 
since it is the major form expressed in all tissues and is gen-
erally overexpressed in fibrotic processes [29]. LH2b, in 
fact, is responsible for the over-hydroxylation of the COL 
telopeptides, forming COL pyridinoline cross-links, thus 
contributing to unwanted COL accumulation [29].  
Our first aim was to characterize collagen turnover path-
ways in untreated aging gingival fibroblasts, compared to 
young ones. COL content, as shown by the fibrosis index 
and protein analysis results, is similar in young and aging 
subjects. Moreover, our results show unchanged MMP-1 as 
well as TIMP-1 mRNA levels, and similar MMP-1 and 
MMP-2 protein levels, suggesting that gingival collagen con-
tent is not regulated at the level of its degradation. This was 
consistent by the increased LH2b/COL-I mRNA ratio (indi-
cating the gene expression of LH2b relative to COL-I). Al-
though the LH2b/COL-I mRNA ratio increased due to de-
creased COL-I mRNA levels with age, we can hypothesize 
that the newly synthesized collagen could be more suscepti-
ble to be cross-linked in aged compared to young gingival 
fibroblasts, and therefore less susceptible to degradation 
[30]. This hypothesis is consistent with the finding of COL-I 
mRNA levels down-regulation in aging fibroblasts, of a 

















Fig. (2). a) Bar graphs showing COL-I, MMP-1, TIMP-1, TGF-1 
and LH2b mRNA levels, and the LH2b/COL-I mRNA ratio in 
young and aging cultured fibroblasts. Changes in mRNA are nor-
malized on GAPDH gene expression. Values are means ± SD for 
duplicate samples. * indicates a significant difference (p < 0.05, 
unpaired Student’s t test). b) Representative gelatin zymogram of 
MMPs in serum-free, conditioned human gingival fibroblast super-
natants from young and aging gingival. The lytic bands weighing 
66 kDa and in the 60/50 kDa region correspond to proMMP-1 and 
proMMP-2, respectively. c) Bar graphs showing proMMP-1 and 
proMMP-2 levels in fibroblast serum-free conditioned media after 
densitometric analysis of lytic bands following SDS-zymography. 
Data are expressed as densitometric units and are means ± SD. 224    The Open Dentistry Journal, 2009, Volume 3  Gagliano et al. 
the experimental groups, together with a similar MMPs ac-
tivity, suggesting that in young and aging gingival collagen 
regulation may be very likely dependent in part on the matu-
ration pathways carried out by post-translational modifica-
tions such as collagen crosslinking.  
The overall balance of COL turnover is controlled also 
by TGF-1, a multifunctional cytokine known to be involved 
in both healing and fibrogenic processes, being capable of 
regulating cell proliferation and differentiation as well as 
directly activating gene expression for the synthesis of ECM 
components [31]. Also TGF-1 gene expression was un-
changed in aging fibroblasts, suggesting a similar tone of 
TGF- 1 influencing collagen turnover. 
SPARC is an important multifunctional glycoprotein that 
modulates cellular interactions with ECM by its binding to 
structural matrix proteins [32]. In adults, the expression of 
SPARC is limited to tissues undergoing repair or remodel-
ling, and healthy gingival connective tissue is a remodelling 
tissue with high turnover [33, 34]. Since SPARC protein 
levels seem not significantly affected by the aging process, 
we can hypothesize that gingival connective tissue remodel-
ling occurs at a similar extent in young and aged people. 
Our second aim was to analyze the effect of CsA on col-
lagen turnover in healthy aging gingival fibroblasts, com-
pared to young ones. Our results show that collagen turnover 
pathways are similarly affected by CsA treatment in young 
and aging gingival fibroblasts. Aging induced the increase of 
collagen protein levels and TIMP-1 mRNA down-regulation, 
but we did not find any statistical difference due to aging-
CsA interaction, and therefore the described differences be-
tween young and aging CsA-treated fibroblasts are due to 
aging itself and not to CsA administration. Considered as a 
whole, these findings suggest that young and aging gingival 






















Fig. (3). Bar graphs showing mRNA levels for COL-I (a), MMP-1 (b), TIMP-1 (c), TGF-1 (d), LH2b (e), and SPARC (f) in VH and CsA-
treated gingival fibroblasts obtained from young and aging healthy donors. mRNA are normalized on GAPDH gene expression. Values are 
means ± SD for duplicate samples.  VH: vehicle. Gingival Collagen Turnover During Aging  The Open Dentistry Journal, 2009, Volume 3    225 
CONCLUSION 
Considered as a whole, the present study offers new in-
sights on the relationship between aging and gingival con-
nective tissue homeostasis. Our results show that in the ab-
sence of any critical disorder in healthy aged people, gingi-
val connective tissue is characterized by a similar collagen 
content and turnover, suggesting that in the senescent pheno-
type, the complex machinery that controls collagen turnover 
is balanced. We hypothesized that, since in the elderly the 
defence machinery against the xenobiotic is weakened, and 
since the elderly use a higher number of medications, they 
are more susceptible to drug effects due to diminished ability 
to maintain tissue homeostasis. In particular, interstitial col-
lagen is the main component of gingival connective tissue 
and its turnover is the target of several drugs leading to GO, 
such as CsA. Although collagen turnover is the main target 
of CsA in gingival fibroblasts, our results show that during 
aging, CsA administration is not related to relevant collagen 
turnover modifications, and that CsA treatment affects colla-
gen turnover pathways at a similar extent in young and aging 
gingival fibroblasts. 
The post hoc assessment of the power of the study re-
vealed that in some occasions a type II error was committed. 
As a consequence, this study presents a limit due to the 
number of the analyzed subjects: the lack of statistical sig-
nificance should be taken with caution. However, our results 
concerning the effect of CsA administration on young and 
aging healthy gingival fibroblasts are consistent since COL-I 
and MMP-1 are the main targets of CsA, and the power of 
the study for these two parameters was > 0.88. 
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